Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-145
Closed -$17.3K 2408
2026
Q1
$17.3K Sell
145
-77
-35% -$10.1K ﹤0.01% 1588
2025
Q4
$30.2K Buy
222
+218
+5,450% +$31.4K ﹤0.01% 1347
2025
Q3
$590 Hold
4
﹤0.01% 1813
2025
Q2
$517 Sell
4
-96
-96% -$11.6K ﹤0.01% 1826
2025
Q1
$11.9K Sell
100
-16
-14% -$1.98K ﹤0.01% 1295
2024
Q4
$13.5K Sell
116
-36
-24% -$4.55K ﹤0.01% 1285
2024
Q3
$20.5K Buy
152
+2
+1% +$268 ﹤0.01% 1193
2024
Q2
$20.3K Buy
+150
New +$20.4K ﹤0.01% 1155
2023
Q4
Sell
-1,000
Closed -$91K 1848
2023
Q3
$91K Hold
1,000
﹤0.01% 797
2023
Q2
$113K Buy
+1,000
New +$106K ﹤0.01% 758
2018
Q4
Sell
-2,000
Closed -$160K 1207
2018
Q3
$160K Buy
+2,000
New +$149K 0.01% 681
2017
Q1
Sell
-300
Closed -$15K 1092
2016
Q4
$15K Buy
+300
New +$15.2K ﹤0.01% 993

Other funds holding XYL

Ancora Advisors's XYL Position: Q2 2026 in Review

Ancora Advisors sold out of Xylem (XYL) in Q2 2026, closing a stake of 145 shares — an estimated $17.3K sold.

Ancora Advisors first reported a position in XYL in Q4 2016 and held it in 12 quarters. The position peaked at $160K in Q3 2018. 1,098 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Ancora Advisors reported no remaining Xylem position as of Q2 2026 after selling out during the quarter.
  • Ancora Advisors sold 145 Xylem shares in Q2 2026, an estimated $17.3K.
  • Ancora Advisors first reported a position in Xylem in Q4 2016 and held it in 12 quarters.
  • Ancora Advisors's Xylem position peaked at $160K in Q3 2018.
  • 1,098 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Ancora Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.